Cited by 15

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Crystallization and preliminary X-ray diffraction analysis of apolipoprotein E-containing lipoprotein particles

Newhouse, Yvonne, Peters-Libeu, Clare, Weisgraber, Karl H.·2005·Acta Crystallographica Section F Structural Biology and Crystallization Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1107/s1744309105032410

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Resolution of this model was limited to around 10Å.

    “However, resolution of this model was limited to around 10Å.”

    From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [58]

    The Results and discussion section reports diffraction data collected to 10–12 Å and maximum resolutions of 10 Å for two crystal forms and 8.5 Å for a third. Those figures support an approximate 10 Å limit for the diffraction data, but the paper does not report a structural model whose resolution was limited to 10 Å. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • As DPPC lipidation results in small particles, typically of the size referred to as "lipid-poor" ApoE, this conformation may reflect nascent ApoE prior to further lipidation by ABCA1.

    “As DPPC lipidation results in small particles, typically of the size referred to as “lipid-poor” ApoE, this conformation may reflect nascent ApoE prior to further lipidation by ABCA1 [17, 25, 57, 58].”

    From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [58]

    The Results and discussion report small apoE4–DPPC particles measuring 60 × 80 Å, supporting the particle-size portion of the sentence. The paper does not call them “lipid-poor” or discuss whether their conformation reflects nascent ApoE before further lipidation by ABCA1. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • X-ray crystallography of DPPC lipidated ApoE revealed that ApoE was present in a spheroidal particle and proposed a "horseshoe" conformation of ApoE.

    “Studies using X-ray crystallography of dipalmitoylphosphatidylcholine (DPPC) lipidated ApoE revealed that ApoE was present in a spheroidal particle and proposed a “horseshoe” conformation of ApoE [57, 58].”

    From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [58]

    The Results and discussion section reports crystallization and preliminary X-ray diffraction of apoE4–DPPC particles, with two apoE molecules per particle and evidence of twofold symmetry. It does not describe the particles as spheroidal or propose a “horseshoe” conformation; those structural details are not supported by this source. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • In this model, the helical domains self-associate and form a semicircular arc around the spheroidal particle.

    “In this model, the helical domains self-associate and form a semicircular arc around the spheroidal particle.”

    From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [58]

    The Results and discussion section reports two apoE molecules with similar molecular envelopes on the particle surface, which supports part of the proposed arrangement. It does not describe helical domains self-associating or forming a semicircular arc; searches for those terms found no such passage in our copy. No page number is available in the indexed text. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • It is unclear if the crystallization procedure altered the structure of the lipoprotein as a result of the crystal packing.

    “It is also unclear if the crystallization procedure altered the structure of the lipoprotein as a result of the crystal packing.”

    From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [58]

    The Results and discussion section reports that dissolved crystals contained intact lipoprotein particles and describes their crystal symmetry, but it does not address whether crystal packing altered the particles’ structure. Searches for crystal packing and structural changes found no passage making that assessment. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. Arnold, K. S., Innerarity, T. L., Pitas, R. E. & Mahley, R. W. (1992). Lipoprotein Analysis. A Practical Approach, edited by C. A. Converse & E. R. Skinner, pp. 145–168. Oxford University Press.
  2. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L. & Pericak-Vance, M. A. (1993). Science, 261, 921–923. [DOI] [PubMed] [Google Scholar]
  3. Dong, L.-M., Innerarity, T. L., Arnold, K. S., Newhouse, Y. M. & Weisgraber, K. H. (1998). J. Lipid Res.39, 1173–1180. [PubMed] [Google Scholar]
  4. Drory, V. E., Birnbaum, M., Korczyn, A. D. & Chapman, J. (2001). J. Neurol. Sci.190, 17–20. [DOI] [PubMed] [Google Scholar]
  5. Fazekas, F., Strasser-Fuchs, S., Schmidt, H., Enzinger, C., Ropele, S., Lechner, A., Flooh, E., Schmidt, R. & Hartung, H.-P. (2000). J. Neurol. Neurosurg. Psychiatry, 69, 25–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Innerarity, T. L., Pitas, R. E. & Mahley, R. W. (1979). J. Biol. Chem.254, 4186–4190. [PubMed] [Google Scholar]
  7. Kabsch, W. (1993). J. Appl. Cryst.26, 795–800. [Google Scholar]
  8. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). J. Biol. Chem.193, 265–275. [PubMed] [Google Scholar]
  9. McIntosh, T. J. & Simon, S. A. (1986). Biochemistry, 25, 4058–4066. [DOI] [PubMed] [Google Scholar]
  10. Mahley, R. W. (1988). Science, 240, 622–630. [DOI] [PubMed] [Google Scholar]
  11. Mahley, R. W., Ji, Z.-S., Brecht, W. J., Miranda, R. D. & He, D. (1994). Ann. NY Acad. Sci.737, 39–52. [DOI] [PubMed] [Google Scholar]
  12. Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.-X., Ginsberg, H., Chun, M., Tycko, B. & Shelanski, M. (1995). Neurology, 45, 555–557. [DOI] [PubMed] [Google Scholar]
  13. Pitas, R. E., Innerarity, T. L., Arnold, K. S. & Mahley, R. W. (1979). Proc. Natl Acad. Sci. USA, 76, 2311–2315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Roses, A. D. & Saunders, A. M. (1997). Ann. NY Acad. Sci.826, 200–212. [DOI] [PubMed] [Google Scholar]
  15. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D. & Roses, A. D. (1993). Neurology, 43, 1467–1472. [DOI] [PubMed] [Google Scholar]
  16. Slooter, A. J. C., Tang, M.-X., van Duijn, C. M., Stern, Y., Ott, A., Bell, K., Breteler, M. M. B., Van Broeckhoven, C., Tatemichi, T. K., Tycko, B., Hofman, A. & Mayeux, R. (1997). J. Am. Med. Assoc.277, 818–821. [DOI] [PubMed]
  17. Small, D. M. (1986). The Physical Chemistry of Lipids. From Alkanes to Phospholipids, pp. 512–517. New York: Plenum Press.
  18. Sorci-Thomas, M., Kearns, M. W. & Lee, J. P. (1993). J. Biol. Chem.268, 21403–21409. [PubMed] [Google Scholar]
  19. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S. & Roses, A. D. (1993). Proc. Natl Acad. Sci. USA, 90, 1977–1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Teasdale, G. M., Nicoll, J. A. R., Murray, G. & Fiddes, M. (1997). Lancet, 350, 1069–1071. [DOI] [PubMed] [Google Scholar]
  21. Weisgraber, K. H. (1994). Adv. Protein Chem.45, 249–302. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Metadata

Authors
Newhouse, Y., Peters-Libeu, C., & Weisgraber, K. H.
Venue
Acta Crystallographica Section F Structural Biology and Crystallization Communications
Published
2005-10-20
Volume
61
Issue
11
Pages
981-984
ISSN
1744-3091
Cited by
15
References
1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review